However, sequence analysis of KRAS or BRAF genes in different pathological regions revealed no oncogenic mutations, suggesting that these mutations may not contribute to tumor progression in Japanese cases of LGSOCs [11]. This evidence concerns the gene KRAS and neoplasm.